H19 and Foxc2 Synergistically Promotes Osteogenic Differentiation of BMSCs Via Wnt-β-catenin Pathway

Overview

Journal J Cell Physiol

Specialties Cell Biology
Physiology

Date 2019 Jan 12

PMID 30633332

Citations 25

Authors

Ping Zhou

Ying Li

Ruolin Di

Yi Yang

Songyan Meng

Fangfang Song

Lan Ma

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the mechanism of H19 on the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).

Methods: Ovariectomized (OVX) mouse model was established. RNA immunoprecipitation and RNA pull-down assays were performed to determine the correlation between H19 and forkhead box C2 (Foxc2). Chromatin immunoprecipitation assay was used to identify whether Foxc2 binds to the Wnt4 promoter region. Molecules expressions were measured by quantitative real-time polymerase chain reaction and western blot.

Results: We found that H19 expression was reduced in the serum of patients with postmenopausal osteoporosis and BMSCs of OVX mice, and overexpression of H19 promoted osteogenic differentiation of BMSCs. Additionally, Foxc2 could bind to the Wnt4 promoter and promote its transcription. We also showed that H19 could bind to Foxc2, and H19/Foxc2 regulated Wnt promoter expression in a synergistic fashion, and H19/Foxc2 regulated osteogenic differentiation of BMSCs through Wnt-β-catenin pathway.

Conclusion: H19 and Foxc2 synergistically promoted osteogenic differentiation of BMSCs via Wnt-β-catenin pathway.

Citing Articles

Jintiange capsule ameliorates glucocorticoid-induced osteonecrosis of the femoral head in rats by regulating the activity and differentiation of BMSCs.

Xu H, Wang L, Zhu X, Zhang H, Chen H, Zhang H J Tradit Complement Med. 2024; 14(5):568-580.

PMID: 39262662 PMC: 11384076. DOI: 10.1016/j.jtcme.2024.03.013.

Long non-coding RNA H19 mediates osteogenic differentiation of bone marrow mesenchymal stem cells through the miR-29b-3p/DKK1 axis.

Qin S, Liu D J Cell Mol Med. 2024; 28(9):e18287.

PMID: 38685675 PMC: 11058329. DOI: 10.1111/jcmm.18287.

Long noncoding RNA (lncRNA) : An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases.

Liao J, Chen B, Zhu Z, Du C, Gao S, Zhao G Genes Dis. 2023; 10(4):1351-1366.

PMID: 37397543 PMC: 10311118. DOI: 10.1016/j.gendis.2023.02.008.

Research Progress on the Osteogenesis-Related Regulatory Mechanisms of Human Umbilical Cord Mesenchymal Stem Cells.

Hu Z, Jiang Z, Meng S, Liu R, Yang K Stem Cell Rev Rep. 2023; 19(5):1252-1267.

PMID: 36917312 DOI: 10.1007/s12015-023-10521-5.

Long non-coding RNAs in osteoporosis: from mechanisms of action to therapeutic potential.

Hou J, Liu D, Zhao J, Qin S, Chen S, Zhou Z Hum Cell. 2023; 36(3):950-962.

PMID: 36881335 DOI: 10.1007/s13577-023-00888-5.